Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00519831 2017-06-09

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Phase 2 Terminated

18 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00408499 2017-05-08

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

Phase 1/2 Completed

64 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00117962 2016-10-07

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 2 Completed

109 enrolled 12 charts

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00216203 2016-09-29

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer

Phase 1/2 Completed

36 enrolled 12 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00124618 2016-07-06

Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 2 Completed

58 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00673738 2015-10-08

Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)

Phase 2 Completed

27 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00406302 2014-04-29

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Phase 2 Completed

41 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00203931 2014-03-31

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

Phase 2 Terminated

55 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00694603 2012-09-06

Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy

Phase 2 Terminated

56 enrolled 6 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00998101 2012-03-06

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00115518 2011-08-05

Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00522886 2011-07-19

Phase I Cetuximab and Concurrent Radio-chemotherapy

Phase 1 Completed

24 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00315185 2010-09-23

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

Phase 2 Completed

53 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01166035 2010-07-20

TEXO

Phase 1/2 Unknown

20 enrolled

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00251498 2008-08-21

Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

82 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00561054 2007-11-20

Coimbra

Phase 2 Unknown

47 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

AFACET

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

ACE-Lung

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)

Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer

Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase I Cetuximab and Concurrent Radio-chemotherapy

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

TEXO

Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

Coimbra